Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Liraglutide in Type 1 Diabetes

This study has been completed.
Sponsor:
Collaborators:
University Hospital, Gentofte, Copenhagen
University of Copenhagen
Information provided by (Responsible Party):
Lise Tarnow, Steno Diabetes Center
ClinicalTrials.gov Identifier:
NCT01612468
First received: May 11, 2012
Last updated: January 26, 2016
Last verified: January 2016